The HHS Secretary has some positive enrollment stats to share, but sentiment shows she and Obama need some reputation rehab.
A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.
The president says current subscribers will be able to keep their plans.
Site fixes are reported to lag, but CMS plans on inviting consumers to give Healthcare.gov another go.
Official numbers are pending, but Reuters notes enrollment appears to be just 3% of the government's goal.
The Centers for Medicare and Medicaid Services won't say if the change is connected to Healthcare.gov's bumpy launch.
General support for the legislation is up, despite Healthcare.gov woes.
They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.
Subscribers will be able to use co-pay cards on Obamacare exchanges.
Five percent of the patient population accounts for 50% of US healthcare costs, one deep dive shows. A major problem: access to medical care.
The short answer: we're not financially prepared for a slowly aging, healthy population, according to a recently published analysis.
Approvals and reviews continue—for now—despite government shutdown.
A roundup of some exchange-related news circling the web.
Growing client demand encouraged the agency to make its HCP content capabilities official.
The midnight shutdown put 800,000 government employees on leave, including those at the FDA, NIH and CDC.
Congress continues to war over healthcare reform. Exchanges will be able to take on members even if the government closes up shop.
Sanofi's PCSK9 agent receives high praise from analysts, Consumer Reports analyzes healthcare reform, Congressional committees propose compounding legislation, NIH funds genomic research.
Despite a possible government standoff, exchanges are coming, as is a proffered rebrand; Amgen signs a university deal in China; Pakistan seeks to rein in pharma; digital marketing is on the rise, research shows
Researchers says growth will average 5.8% a year between 2012 and 2022. They also anticipate generics will hit a leveling-off point that will drive average Rx prices upwards
Sanofi has to provide more Aubagio data to the UK's NICE; healthcare reform's sixes and sevens; NIH puts money toward Alzheimer's research
Benefits research studies show employers expect to lay out 7% more in healthcare costs in 2014, a move that has not been accompanied by lower employee costs.
Takeda moves an Alzheimer's treatment to Phase III; Sangamo acquires Ceregene; Catalyst gets breakthrough designation for auto-immune disorder drug; study says seniors likely to opt out of health insurance
Eli Lilly is accused of misconduct in China, Health and Human Services tries to get young adults interested in health insurance, Novo kid-friendly insulin pen approved; India biotech says its Herceptin biosimilar will launch this year.
Allergan asks FDA to reconsider Restatis generics requirements, Incyte's Jakafi could be pancreatic cancer nemesis, Medtronic says its strategy is at the heart of where healthcare is going and Aetna's app alliance makes health local and personal.
Abbott's Depakote lawsuits roll on; IMS buys mobile health firm's assets; BI shutters a chemical plant; and the healthcare reform back-and-forth continues.
Eisai lobbies to push back Belviq's patent clock; a case against Paula Deen is dismissed; Merck and Avanir team up to promote Januvia; and another healthcare-reform measure is pushed back
Weber Shandwick hired Susan Smirnoff away from the healthcare practice of Ruder Finn, where she had spent more than three decades.
David Schlanger is the company's new chief executive, a role he's filled on an interim basis since May.
J&J sells off its feminine side; Manhattan Research's study on the sales rep "tablet dance"; Cepheid rolls out a consumer TB campaign; and healthcare sector job losses top out in July.
A new survey of doctors reveals how much they know (or don't) about the looming launch of healthcare exchanges.